• Molnupiravir Efficacy Against Bourbon Virus: Preclinical Evi

  2026-05-27

  This study demonstrates that molnupiravir, a broad-spectrum antiviral, significantly inhibits Bourbon virus (BRBV) infection and disease progression in a mouse model. The findings provide foundational evidence for the potential use of nucleoside analogues against emerging tick-borne RNA viruses and highlight the value of rigorous preclinical models for advancing antiviral research.

• Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis Ass

  2026-05-26

  Unlock high-sensitivity, quantitative apoptosis detection using the Caspase-3 Fluorometric Assay Kit. This guide delivers actionable protocol enhancements, troubleshooting strategies, and advanced applications inspired by cutting-edge research on apoptosis–ferroptosis crosstalk.

• Efficacy of Fumagillin Against Azumiobodo hoyamushi in Soft

  2026-05-26

  This study systematically evaluates the in vitro and in vivo antiparasitic efficacy of 20 drugs, including Fumagillin, against Azumiobodo hoyamushi—the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings clarify the moderate potency of Fumagillin and inform practical approaches to disease management in aquaculture settings.

• Hyperthermia and Cisplatin Synergy: Caspase-8 Drives Apoptos

  2026-05-25

  This study reveals how combining hyperthermia with cisplatin therapy enhances cancer cell death by driving caspase-8 polyubiquitination, accumulation, and activation. The findings illuminate a mechanistic link between caspase-8, apoptosis, and pyroptosis, providing new directions for apoptosis assay design and cancer treatment strategies.

• Strategic PCR Mastery: Advancing Translational Oncology Rese

  2026-05-25

  Explore how mechanistic insight into Taq DNA polymerase function—anchored by emerging evidence in colorectal cancer biology—translates into actionable strategies for translational researchers. This article bridges the latest mechanistic discoveries with practical workflow optimization, leveraging APExBIO’s 2X Taq PCR Master Mix (with dye) to empower rapid, reliable molecular investigation in cancer and beyond.

• NHS-Biotin: Precision Biotinylation for Protein Engineering

  2026-05-24

  NHS-Biotin (N-hydroxysuccinimido biotin) provides high-efficiency, amine-specific biotinylation for proteins and antibodies. Its membrane-permeable, short-spacer design enables intracellular protein labeling and streamlines workflows involving protein detection and purification using streptavidin probes. APExBIO's NHS-Biotin (A8002) is benchmarked for stability and reactivity under defined protocol conditions.

• Alosetron and 5-HT3 Antagonism: Redefining Gut Polarity Rese

  2026-05-23

  Explore how Alosetron, a selective 5-HT3 receptor antagonist, empowers translational researchers to dissect gastrointestinal motility and epithelial polarity at the intersection of serotonin receptor pharmacology and advanced stem cell signaling. This article links mechanistic insights to strategic protocol design, highlighting new frontiers in gut homeostasis and disease modeling.

• Dissecting SPEN-XIST A-Repeat Interactions in X Chromosome S

  2026-05-22

  Button et al. provide new mechanistic insight into how the SPEN protein selectively binds the XIST A-repeat RNA to initiate X chromosome inactivation in mammals. Their structure-function analysis reveals the specific RNA and protein domains necessary for high-affinity binding, clarifying molecular determinants of gene silencing and informing advanced RNA-protein interaction studies.

• Morin for Applied Research: Antioxidant and Probe Workflows

  2026-05-22

  Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a versatile natural flavonoid, excelling as an antioxidant, anti-inflammatory agent, and sensitive fluorescent probe for aluminum detection. This guide translates recent mechanistic and protocol innovations into actionable workflows, troubleshooting, and optimization tips for disease modeling and biochemical assays.

• Astrocyte Heterogeneity Mapped Across Mouse and Marmoset Bra

  2026-05-21

  Schroeder et al. present a comprehensive transcriptomic atlas revealing how astrocyte regional diversity evolves during postnatal brain development in both mouse and marmoset. This resource highlights pronounced regional and species-specific molecular signatures and demonstrates that astrocyte specialization is both developmentally dynamic and morphologically distinct.

• Disaccharide and Lipid Effects in Lyophilized mRNA Lipoplex

  2026-05-21

  This study by Shimizu and Hattori investigates how the choice of cationic lipid and disaccharide cryoprotectant impacts the efficiency and stability of reverse transfection using lyophilized mRNA lipoplexes. Their findings highlight the critical role of lipid structure and sugar concentration in optimizing mRNA delivery platforms for high-throughput screening and potential therapeutic applications.

• Caspase-8 Activation in Hyperthermia and Cisplatin Cancer Th

  2026-05-20

  This study reveals that combining hyperthermia with cisplatin chemotherapy enhances both apoptosis and pyroptosis in cancer cells by promoting caspase-8 accumulation and activation. The findings uncover a previously uncharacterized mechanism involving K63-linked polyubiquitination of caspase-8, providing new directions for programmed cell death research and therapeutic strategy development.

• Trichostatin A (TSA): Benchmark HDAC Inhibitor for Epigeneti

  2026-05-20

  Trichostatin A (TSA) is a potent, reversible HDAC inhibitor crucial for epigenetic regulation research. It enforces cell cycle arrest, enhances histone acetylation, and demonstrates robust antiproliferative effects in cancer models. TSA’s specificity and workflow parameters make it a standard tool for investigating epigenetic mechanisms in oncology.

• WAY-100635: Advancing Translational Pain and Emotion Researc

  2026-05-19

  This article explores the mechanistic, strategic, and translational dimensions of WAY-100635 (N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide), a potent 5-HT1A antagonist. By integrating recent discoveries on serotonin-cannabinoid interplay in orofacial pain and leveraging behavioral, molecular, and imaging paradigms, we delineate a roadmap for researchers aiming to bridge preclinical neuroscience with multidimensional pain and affective disorder models. Real-world protocol guidance and competitive insights are included, with APExBIO's WAY-100635 as a pivotal tool.

• TAK-715: Precision p38 MAPK Inhibitor for Inflammation Resea

  2026-05-19

  TAK-715 enables nanomolar-selective inhibition of p38α MAPK, empowering researchers to dissect cytokine signaling with unmatched precision. This guide translates recent mechanistic breakthroughs and practical workflows into actionable steps for inflammation and rheumatoid arthritis research.

387 records 6/26 page Previous Next First page 上5页 678910 下5页 Last page